نتایج جستجو برای: factor ii g20210a mutation

تعداد نتایج: 1608670  

2000
Valeria Genoud Mercedes Castañon Joyce Annichino-Bizzacchi Jorge Korin

ORIGINAL ARTICLE Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina Valeria Genoud1, Mercedes Castañon1, Joyce Annichino-Bizzacchi2, Jorge Korin1 and Lucı́a Kordich1 on behalf of the Grupo Cooperativo Argentino de Hemostasia y Trombosis 1Facultad de Ciencias Exactas y Naturales. Dpto. Quı́mica Bio...

Journal: :Thrombosis and haemostasis 2005
Manuela Krause Barbara Sonntag Robert Klamroth Achim Heinecke Carola Scholz Claus Langer Inge Scharrer Robert R Greb Arnold von Eckardstein Ulrike Nowak-Göttl

From 1998 to 2003, 133 Caucasian women aged 17-40 years (median 29 years) suffering from unexplained recurrent miscarriage (uRM) were consecutively enrolled. In patients and 133 age-matched healthy controls prothrombotic risk factors (factor V (FV) G1691A, factor II (FII) G20210A, MTHFR T677T, 4G/5G plasminogen activator inhibitor (PAI)-1, lipoprotein (Lp) (a), protein C (PC), protein S (PS), a...

2012
Procházka Václav Procházka

Cerebral venous thrombosis is a relatively rare, however life-threatening condition. Current studies show that around 10% of the patients die. Earlier works proved that most of the thromboses originated secondarily, as a consequence of local or systemic infection, more than 30% of the cases were considered to be idiopathic. More recent studies also mention other risk factors, which may contribu...

1998
Joop H. Jansen Bert A. van der Reijden

1. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994 2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 38-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin le...

1999
Ulrike Nowak-Göttl Ronald Sträter Achim Heinecke Ralf Junker Hans-Georg Koch Gerhard Schuierer

Ischemic stroke is a rare event in childhood. In approximately one third of cases no obvious underlying cause or disorder can be detected. We investigated the importance of genetic risk factors of venous thromboembolism in childhood or stroke in adulthood as risk factors for spontaneous ischemic stroke in children. One hundred forty-eight Caucasian infants and children (aged 0.5 to 16 years) wi...

Journal: :Blood 1999
U Nowak-Göttl R Sträter A Heinecke R Junker H G Koch G Schuierer A von Eckardstein

Ischemic stroke is a rare event in childhood. In approximately one third of cases no obvious underlying cause or disorder can be detected. We investigated the importance of genetic risk factors of venous thromboembolism in childhood or stroke in adulthood as risk factors for spontaneous ischemic stroke in children. One hundred forty-eight Caucasian infants and children (aged 0.5 to 16 years) wi...

2018
Fekri Samarah Mahmoud A Srour

Background Vascular thrombosis is an important pathophysiological aspect of sickle cell disease (SCD). This study aimed to investigate the prevalence and clinical impact of factor V Leiden G1691A (FVL) and prothrombin G20210A mutations among Palestinian sickle cell disease (SCD) patients. Methods A total of 117 SCD patients, including 59 patients with sickle cell anemia (SS), 33 patients with...

Journal: :American journal of clinical pathology 2012
Riley B Ballard Marisa B Marques

Venous thromboembolism (VTE) results from the interaction of the Virchow triad (venous stasis, endothelial injury, and hypercoagulability). Risk factors for increased hypercoagulability, or thrombophilia, include activated protein C resistance/factor V Leiden, the prothrombin G20210A mutation, deficiencies of the natural anticoagulants (antithrombin, proteins C and S), antiphospholipid antibodi...

Journal: :Blood 2003
Rory R Koenen Guido Tans René van Oerle Karly Hamulyák Jan Rosing Tilman M Hackeng

Protein S exhibits anticoagulant activity independent of activated protein C (APC). An automated factor Xa-based one-stage clotting assay was developed that enables quantification of the APC-independent activity of protein S in plasma from the ratio of clotting times (protein S ratio [pSR]) determined in the absence and presence of neutralizing antibodies against protein S. The pSR was 1.62 +/-...

Journal: :Stroke 2003
Alessandro Pezzini Elisabetta Del Zotto Mauro Magoni Angelo Costa Silvana Archetti Mario Grassi Nabil Maalikjy Akkawi Alberto Albertini Deodato Assanelli Luigi Amedeo Vignolo Alessandro Padovani

BACKGROUND AND PURPOSE The pathogenic link between patent foramen ovale (PFO) and stroke remains unknown in most cases. We investigated the association between inherited thrombophilic disorders and PFO-related strokes in a series of young adults in the setting of a case-control study. METHODS We investigated 125 consecutive subjects (age, 34.7+/-7.3 years) with ischemic stroke and 149 age- an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید